Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Energy
DIG
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
Mineralys Therapeutics (MLYS)
- 23.940
- +0.180+0.76%
Close Jun 11 16:00 ET
- 23.800
- -0.140-0.58%
Post 20:01 ET
2.11BMarket Cap-12.15P/E (TTM)
24.010High23.320Low1.54MVolume23.800Open23.760Prev Close36.55MTurnover2.34%Turnover RatioLossP/E (Static)88.16MShares47.65052wk High3.31P/B1.58BFloat Cap12.59052wk Low--Dividend TTM66.03MShs Float47.650Historical High--Div Yield TTM2.90%Range %5.850Historical Low23.670Avg Price1Lot Size
Mineralys Therapeutics (MLYS) Key Financial Indicators
MLYS Earnings per Share (EPS)
According to the latest financial report of Mineralys Therapeutics, the latest earnings per share (TTM) for the company is -0.47. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
MLYS Free Cash Flow (FCF)
Interested in knowing about Mineralys Therapeutics's free cash flow? The latest report shows it as -39.47M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
MLYS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Mineralys Therapeutics shows that the company's current ratio is 44.33, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
MLYS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Mineralys Therapeutics, the quick ratio is 43.90, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
MLYS Return on Equity (ROE)
Want to learn more about the financial health of Mineralys Therapeutics? The latest ROE figure is -6.12%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
MLYS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Mineralys Therapeutics, the total asset return on investment (ROA) is -5.98%.
Currency: USD
Quarterly
Loading...
MLYS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Mineralys Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
MLYS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Mineralys Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran conflict shows signs of easing. On the 11th, Eastern Time, Trump revealed that the United States and Iran are expected to reac
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm